Logo image of CCD

CALAMOS DYN CONVERT & INC (CCD) Stock Price, Quote, News and Overview

NASDAQ:CCD - Nasdaq - US12811V1052 - Currency: USD

21.87  +0.11 (+0.51%)

Fundamental Rating

2

CCD gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. Both the profitability and financial health of CCD have multiple concerns. CCD has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CCD has reported negative net income.
In the past year CCD had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CCD reported negative net income in multiple years.
CCD had a positive operating cash flow in 4 of the past 5 years.
CCD Yearly Net Income VS EBIT VS OCF VS FCFCCD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M -400M -600M

1.2 Ratios

Industry RankSector Rank
ROA -7.53%
ROE -12.05%
ROIC 2.02%
ROA(3y)-3.47%
ROA(5y)3.4%
ROE(3y)-6.65%
ROE(5y)4.06%
ROIC(3y)4.77%
ROIC(5y)4.81%
CCD Yearly ROA, ROE, ROICCCD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

1.3 Margins

In the last couple of years the Operating Margin of CCD has declined.
CCD's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 50.38%
PM (TTM) N/A
GM 50.79%
OM growth 3Y-5.09%
OM growth 5Y-2.9%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.08%
GM growth 5Y-2.88%
CCD Yearly Profit, Operating, Gross MarginsCCD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 -200 -400 -600

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, CCD has more shares outstanding
The number of shares outstanding for CCD has been increased compared to 5 years ago.
The debt/assets ratio for CCD is higher compared to a year ago.
CCD Yearly Shares OutstandingCCD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
CCD Yearly Total Debt VS Total AssetsCCD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 1.25, we must say that CCD is in the distress zone and has some risk of bankruptcy.
The Debt to FCF ratio of CCD is 4.67, which is a neutral value as it means it would take CCD, 4.67 years of fcf income to pay off all of its debts.
CCD has a Debt/Equity ratio of 0.59. This is a neutral value indicating CCD is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 4.67
Altman-Z 1.25
ROIC/WACCN/A
WACCN/A
CCD Yearly LT Debt VS Equity VS FCFCCD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M

2.3 Liquidity

A Current Ratio of 9.15 indicates that CCD has no problem at all paying its short term obligations.
A Quick Ratio of 9.15 indicates that CCD has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 9.15
Quick Ratio 9.15
CCD Yearly Current Assets VS Current LiabilitesCCD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 93.07% over the past year.
Looking at the last year, CCD shows a very strong growth in Revenue. The Revenue has grown by 22.15%.
CCD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.25% yearly.
EPS 1Y (TTM)93.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.24%
Revenue 1Y (TTM)22.15%
Revenue growth 3Y1.56%
Revenue growth 5Y0.25%
Sales Q2Q%828.61%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CCD Yearly Revenue VS EstimatesCCD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CCD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CCD Price Earnings VS Forward Price EarningsCCD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 9.1
EV/EBITDA N/A
CCD Per share dataCCD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

CCD has a Yearly Dividend Yield of 10.90%, which is a nice return.
CCD's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 10.9%

5.2 History

The dividend of CCD has a limited annual growth rate of 0.93%.
CCD has been paying a dividend for at least 10 years, so it has a reliable track record.
CCD has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)0.93%
Div Incr Years0
Div Non Decr Years8
CCD Yearly Dividends per shareCCD Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

CCD has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-88.33%
EPS Next 2YN/A
EPS Next 3YN/A
CCD Yearly Income VS Free CF VS DividendCCD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M -400M -600M

More info and screens

CALAMOS DYN CONVERT & INC

NASDAQ:CCD (5/2/2025, 8:00:02 PM)

21.87

+0.11 (+0.51%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners15.77%
Inst Owner Change-0.77%
Ins Owners4.8%
Ins Owner Change0%
Market Cap587.87M
Analysts0
Price TargetN/A
Short Float %0.8%
Short Ratio2.29
Dividend
Industry RankSector Rank
Dividend Yield 10.9%
Yearly Dividend2.07
Dividend Growth(5Y)0.93%
DP-88.33%
Div Incr Years0
Div Non Decr Years8
Ex-Date04-11 2025-04-11 (0.195)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 14.28
P/FCF 9.1
P/OCF 9.1
P/B 1.15
P/tB 1.15
EV/EBITDA N/A
EPS(TTM)-0.63
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.4
FCFY10.99%
OCF(TTM)2.4
OCFY10.99%
SpS1.53
BVpS18.97
TBVpS18.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.53%
ROE -12.05%
ROCE 2.56%
ROIC 2.02%
ROICexc 2.12%
ROICexgc 2.12%
OM 50.38%
PM (TTM) N/A
GM 50.79%
FCFM 156.89%
ROA(3y)-3.47%
ROA(5y)3.4%
ROE(3y)-6.65%
ROE(5y)4.06%
ROIC(3y)4.77%
ROIC(5y)4.81%
ROICexc(3y)4.94%
ROICexc(5y)4.91%
ROICexgc(3y)4.94%
ROICexgc(5y)4.91%
ROCE(3y)6.04%
ROCE(5y)6.09%
ROICexcg growth 3Y2.1%
ROICexcg growth 5Y-2.98%
ROICexc growth 3Y2.1%
ROICexc growth 5Y-2.98%
OM growth 3Y-5.09%
OM growth 5Y-2.9%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.08%
GM growth 5Y-2.88%
F-Score5
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 4.67
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.89
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.15
Quick Ratio 9.15
Altman-Z 1.25
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)93.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.24%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.15%
Revenue growth 3Y1.56%
Revenue growth 5Y0.25%
Sales Q2Q%828.61%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.94%
EBIT growth 3Y-3.61%
EBIT growth 5Y-2.66%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-12.33%
FCF growth 3Y24.54%
FCF growth 5Y12.89%
OCF growth 1Y-12.33%
OCF growth 3Y24.54%
OCF growth 5Y12.89%